Literature DB >> 5917396

Hypercalcaemia associated with adenocarcinoma of kidney without demonstrable bone lesions.

W H Thomson, A B Karat.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5917396      PMCID: PMC1943923          DOI: 10.1136/bmj.2.5516.745

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  HYPERPARATHYROIDISM AND CANCER.

Authors:  C E DENT; L C WATSON
Journal:  Br Med J       Date:  1964-07-25

2.  PSEUDOHYPERPARATHYROIDISM DUE TO MALIGNANT TUMORS.

Authors:  P A SNEDECOR; H W BAKER
Journal:  Cancer       Date:  1964-11       Impact factor: 6.860

3.  DERANGEMENTS OF CALCIUM METABOLISM IN PATIENTS WITH NEOPLASTIC BONE INVOLVEMENT.

Authors:  H SPENCER; I LEWIN
Journal:  J Chronic Dis       Date:  1963-07

Review 4.  HYPERCALCAEMIA AND CANCER.

Authors:  L WATSON
Journal:  Postgrad Med J       Date:  1963-11       Impact factor: 2.401

5.  HYPERCALCEMIA IN PATIENTS WITH MALIGNANT LYMPHOMA.

Authors:  A M MOSES; H SPENCER
Journal:  Ann Intern Med       Date:  1963-10       Impact factor: 25.391

6.  RENAL ADENOCARCINOMA CONTAINING A PARATHYROID HORMONE-LIKE SUBSTANCE AND ASSOCIATED WITH MARKED HYPERCALCEMIA.

Authors:  M F GOLDBERG; A H TASHJIAN; S E ORDER; G J DAMMIN
Journal:  Am J Med       Date:  1964-05       Impact factor: 4.965

7.  PARATHYROID FUNCTION AND PRIMARY HYPERPARATHYROIDISM.

Authors:  A R HARRISON
Journal:  Sci Basis Med Annu Rev       Date:  1963

8.  [Hypernephroid carcinoma of the left kidney with symptoms of primary hyperparathyroidism].

Authors:  D BORM
Journal:  Endokrinologie       Date:  1961-09

9.  Hypercalcemia in neoplastic disease.

Authors:  W P MYERS
Journal:  Arch Surg       Date:  1960-02

10.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

View more
  1 in total

1.  Concurrence of hypernephroma and hypercalcemia.

Authors:  M M Warren; D C Utz; P P Kelalis
Journal:  Ann Surg       Date:  1971-11       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.